Gaining insights into the molecular mechanisms by which elevated SOX2 arrests the growth of tumor cells could identify therapeutic targets for the eradication of quiescent tumor-initiating cells, thus helping to address a major unmet need. Here, SOX2 is linked to neoplasm.